ACIP's slides on mRNA vaccines and myocarditis are now available cdc.gov/vaccines/acip/…
Hard to argue this isn't causal
The signal by age and dose is not ambiguous
Risk clearly seems highest among young males
Important to note: anyone can report anything to VAERS
When they dig into 29 *confirmed* cases:
- majority were hospitalized
- 2 required ICU care
- all were eventually discharged
The rates here are a bit misleading because teens are lumped in with twenty- and thirtysomethings. (To be fair, they have to do this because counts are so low.)
It's fair to call vaccine-associated myocarditis rare or very rare. And it's reassuring that most of those who develop it do well.
Still waiting to see more detail from Israel sciencemag.org/news/2021/06/i…
I am a big proponent of vaccination, but I think it's fair to ask a question:
What is the incremental benefit of a second dose in young males (say, under 25), especially as more and more older people are fully vaccinated?
/ end
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.